OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 12, 2022
Using a predictive modeling approach can help tighten up operator control over bioprocessing, which in turn can increase bioreactor output.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
October 02, 2022
The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.
August 02, 2022
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
July 02, 2022
Industry adoption of plant-made biologics remains slow, but plant-based technology gains an advantage by mainstream exposure.
June 27, 2022
MilliporeSigma’s new BioContinuum Seed Train Platform offering enables a fully closed bioprocessing environment for both fed-batch and perfusion N-production.
June 10, 2022
The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.
May 02, 2022
Workforce training is crucial for biopharmaceutical manufacturing.
April 02, 2022
The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.
March 02, 2022
The use of bioengineering offers practical tools for the evolution of host cells.